Association of low-dose succinylcholine pretreatment with fasciculation severity, haemodynamic variability, and respiratory recovery during modified electroconvulsive therapy: a retrospective cohort study
This retrospective cohort study of 75 patients undergoing modified electroconvulsive therapy found that low-dose (10 mg) succinylcholine pretreatment significantly reduced fasciculation severity, systolic blood pressure variability, and respiratory recovery time compared to no pretreatment, though the authors note these hypothesis-generating results require confirmation in prospective randomized trials.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For many people living with severe depression or other difficult psychiatric conditions, standard medications and therapies sometimes fall short. When these treatments fail, doctors may turn to a procedure called modified electroconvulsive therapy, often known as MECT. In this treatment, a carefully controlled electrical current is passed through the brain to trigger a brief seizure, which can reset chemical pathways and offer relief where other methods have not. To keep the experience safe and comfortable, patients are given anesthesia to make them sleep and a muscle relaxant to prevent their bodies from shaking violently during the seizure. However, the muscle relaxant used most often, a drug called succinylcholine, has a known side effect: just before it fully works, it can cause sudden, involuntary muscle twitches called fasciculations. These twitches can be uncomfortable and may also cause a temporary spike in heart rate and blood pressure, which can be risky for some patients. Doctors have long wondered if giving a tiny, harmless dose of this same muscle relaxant a minute before the main dose could calm the body down and prevent those twitches, but there has been very little direct evidence to confirm if this trick works during MECT.
A team of researchers at Hangzhou Seventh People's Hospital in China decided to look back at their own records to find out. They examined the experiences of 75 patients who underwent this therapy over a two-year period. The patients were split into two groups based on the routine care they received. One group received a small, ten-milligram dose of succinylcholine one minute before the main anesthesia and muscle relaxant were given. The other group received a harmless saltwater injection instead, followed by the standard treatment. The researchers then watched closely to see if the tiny pre-dose made a difference in three specific areas: how severe the muscle twitches were, how stable the patients' blood pressure remained during the procedure, and how quickly they started breathing on their own after the treatment ended.
The results showed a clear pattern favoring the group that received the small pre-dose. In terms of muscle twitches, the difference was noticeable. Nearly half of the patients who got the pre-dose showed no visible twitching at all, compared to only about a quarter of those who did not. For the patients who did twitch, the movements were generally milder. This suggests that the small initial dose may have helped the muscles settle before the larger dose arrived, reducing the chaotic reaction that usually occurs. Beyond just the muscles, the patients who received the pre-dose also showed more stable blood pressure. When the researchers measured how much the blood pressure fluctuated from the start of the procedure until the end, the group with the pre-dose had significantly less variation. This is important because large swings in blood pressure can be dangerous for patients with heart or brain conditions.
Perhaps the most practical finding concerned how quickly the patients woke up and began breathing normally again. The group that received the ten-milligram pre-dose started breathing on their own about forty-eight seconds faster than the group that did not. While less than a minute might seem like a small amount of time, in a hospital setting where patients undergo multiple sessions over several weeks, saving nearly a minute per session adds up to a meaningful reduction in total recovery time. The researchers also checked for other side effects, such as headaches or nausea, and found that the rates were similar between the two groups, with no serious safety concerns arising from the pre-dose.
It is important to understand that this study looked back at past records rather than running a new, controlled experiment where patients were randomly assigned to groups. Because of this, the researchers cannot say with absolute certainty that the pre-dose caused these improvements; other differences between the patients, such as their height or the specific type of anesthesia they received, could have played a role. The study was also conducted at a single hospital with a relatively small number of participants. Despite these limitations, the findings are strong enough to suggest that this simple adjustment is worth testing further. The data indicates that giving a tiny amount of the muscle relaxant before the main dose appears to make the procedure smoother, safer, and slightly faster for patients, offering a promising lead for future research to confirm whether this simple step can become a standard part of care.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.